TREM-1 orchestrates angiotensin II–induced monocyte trafficking and promotes experimental abdominal aortic aneurysm

The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II-induced (AngII-induced) A...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation Vol. 131; no. 2; pp. 1 - 14
Main Authors: Vandestienne, Marie, Zhang, Yujiao, Santos-Zas, Icia, Al-Rifai, Rida, Joffre, Jeremie, Giraud, Andreas, Laurans, Ludivine, Esposito, Bruno, Pinet, Florence, Bruneval, Patrick, Raffort, Juliette, Lareyre, Fabien, Vilar, Jose, Boufenzer, Amir, Guyonnet, Lea, Guerin, Coralie, Clauser, Eric, Silvestre, Jean-Sébastien, Lang, Sylvie, Soulat-Dufour, Laurie, Tedgui, Alain, Mallat, Ziad, Taleb, Soraya, Boissonnas, Alexandre, Derive, Marc, Chinetti, Giulia, Ait-Oufella, Hafid
Format: Journal Article
Language:English
Published: United States American Society for Clinical Investigation 19.01.2021
Subjects:
ISSN:0021-9738, 1558-8238, 1558-8238
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II-induced (AngII-induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages. Trem1 gene deletion (Apoe-/-Trem1-/-), as well as TREM-1 pharmacological blockade with LR-12 peptide, limited both AAA development and severity. Trem1 gene deletion attenuated the inflammatory response in the aorta, with a reduction of Il1b, Tnfa, Mmp2, and Mmp9 mRNA expression, and led to a decreased macrophage content due to a reduction of Ly6Chi classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated Ly6Chi monocyte aorta infiltration after AngII infusion through CD62L upregulation and promoted proinflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on Ly6Chi monocytes through AngII receptor type I (AT1R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared with patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in humans.
AbstractList The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II–induced (AngII–induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages. Trem1 gene deletion (Apoe–/–Trem1–/–), as well as TREM-1 pharmacological blockade with LR-12 peptide, limited both AAA development and severity. Trem1 gene deletion attenuated the inflammatory response in the aorta, with a reduction of Il1b, Tnfa, Mmp2, and Mmp9 mRNA expression, and led to a decreased macrophage content due to a reduction of Ly6Chi classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated Ly6Chi monocyte aorta infiltration after AngII infusion through CD62L upregulation and promoted proinflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on Ly6Chi monocytes through AngII receptor type I (AT1R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared with patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in humans.
The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II-induced (AngII-induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages. Tremi gene deletion (Apoe-/-Trem1-/-), as well as TREM-1 pharmacological blockade with LR-12 peptide, limited both AAA development and severity. Tremi gene deletion attenuated the inflammatory response in the aorta, with a reduction of Illb, Tnfa, Mmp2, and Mmp9 mRNA expression, and led to a decreased macrophage content due to a reduction of Ly6Chi classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated Ly6Chi monocyte aorta infiltration after AngII infusion through CD62L upregulation and promoted proinflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on Ly6Chi monocytes through AngII receptor type I (AT1R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared with patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in humans.
The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II-induced (AngII-induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages. Trem1 gene deletion (Apoe-/-Trem1-/-), as well as TREM-1 pharmacological blockade with LR-12 peptide, limited both AAA development and severity. Trem1 gene deletion attenuated the inflammatory response in the aorta, with a reduction of Il1b, Tnfa, Mmp2, and Mmp9 mRNA expression, and led to a decreased macrophage content due to a reduction of Ly6Chi classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated Ly6Chi monocyte aorta infiltration after AngII infusion through CD62L upregulation and promoted proinflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on Ly6Chi monocytes through AngII receptor type I (AT1R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared with patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in humans.The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin II-induced (AngII-induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages. Trem1 gene deletion (Apoe-/-Trem1-/-), as well as TREM-1 pharmacological blockade with LR-12 peptide, limited both AAA development and severity. Trem1 gene deletion attenuated the inflammatory response in the aorta, with a reduction of Il1b, Tnfa, Mmp2, and Mmp9 mRNA expression, and led to a decreased macrophage content due to a reduction of Ly6Chi classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated Ly6Chi monocyte aorta infiltration after AngII infusion through CD62L upregulation and promoted proinflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on Ly6Chi monocytes through AngII receptor type I (AT1R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared with patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in humans.
The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of angiotensin Il-induced (AngII-induced) AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalized with macrophages. Treml gene deletion ([Apoe.sup.-/-] [Trem1.sup.-/-]), as well as TREM-1 pharmacological blockade with LR-12 peptide, limited both AAA development and severity. Treml gene deletion attenuated the inflammatory response in the aorta, with a reduction of Il1b, Tnfa, Mmp2, and Mmp9 mRNA expression, and led to a decreased macrophage content due to a reduction of [Ly6C.sup.hi] classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated [Ly6C.sup.hi] monocyte aorta infiltration after AngII infusion through CD62L upregulation and promoted proinflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on [Ly6C.sup.hi] monocytes through AngII receptor type I ([AT.sub.1]R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared with patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in humans.
Audience Academic
Author Joffre, Jeremie
Boissonnas, Alexandre
Esposito, Bruno
Giraud, Andreas
Santos-Zas, Icia
Mallat, Ziad
Clauser, Eric
Laurans, Ludivine
Lang, Sylvie
Silvestre, Jean-Sébastien
Zhang, Yujiao
Pinet, Florence
Guyonnet, Lea
Taleb, Soraya
Al-Rifai, Rida
Boufenzer, Amir
Vandestienne, Marie
Bruneval, Patrick
Derive, Marc
Ait-Oufella, Hafid
Guerin, Coralie
Vilar, Jose
Tedgui, Alain
Soulat-Dufour, Laurie
Chinetti, Giulia
Raffort, Juliette
Lareyre, Fabien
AuthorAffiliation 12 Medical Intensive Care Unit, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France
2 INSERM U1167-Institut Pasteur de Lille, Lille, France
4 Université Côte d’Azur, Centre Hospitalo-Universitaire (CHU), INSERM, C3M, Nice, France
3 Department of Anatomopathology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
7 Institut Curie, Cytometry Platform F-75006, Paris, France
6 Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, Paris, France
8 Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg, Luxembourg
1 Université de Paris, Inserm U970, Paris-Cardiovascular Research Center, Paris, France
11 Sorbonne Université, INSERM, CNRS, Centre d’Immunologie et des Maladies Infectieuses Cimi-Paris, Paris, France
5 INOTREM SA, Nancy, France
9 Cardiology Department, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France
10 Department of Medicine, Division of Cardiovascular Medicine, Universi
AuthorAffiliation_xml – name: 8 Department of Infection and Immunity, Luxembourg Institute of Health, Luxembourg, Luxembourg
– name: 3 Department of Anatomopathology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
– name: 5 INOTREM SA, Nancy, France
– name: 10 Department of Medicine, Division of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom
– name: 7 Institut Curie, Cytometry Platform F-75006, Paris, France
– name: 2 INSERM U1167-Institut Pasteur de Lille, Lille, France
– name: 11 Sorbonne Université, INSERM, CNRS, Centre d’Immunologie et des Maladies Infectieuses Cimi-Paris, Paris, France
– name: 6 Université de Paris, Innovative Therapies in Haemostasis, INSERM, F-75006, Paris, France
– name: 4 Université Côte d’Azur, Centre Hospitalo-Universitaire (CHU), INSERM, C3M, Nice, France
– name: 1 Université de Paris, Inserm U970, Paris-Cardiovascular Research Center, Paris, France
– name: 9 Cardiology Department, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France
– name: 12 Medical Intensive Care Unit, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, Paris, France
Author_xml – sequence: 1
  givenname: Marie
  orcidid: 0000-0002-6947-9852
  surname: Vandestienne
  fullname: Vandestienne, Marie
– sequence: 2
  givenname: Yujiao
  orcidid: 0000-0002-0982-858X
  surname: Zhang
  fullname: Zhang, Yujiao
– sequence: 3
  givenname: Icia
  surname: Santos-Zas
  fullname: Santos-Zas, Icia
– sequence: 4
  givenname: Rida
  orcidid: 0000-0002-6976-0011
  surname: Al-Rifai
  fullname: Al-Rifai, Rida
– sequence: 5
  givenname: Jeremie
  surname: Joffre
  fullname: Joffre, Jeremie
– sequence: 6
  givenname: Andreas
  surname: Giraud
  fullname: Giraud, Andreas
– sequence: 7
  givenname: Ludivine
  surname: Laurans
  fullname: Laurans, Ludivine
– sequence: 8
  givenname: Bruno
  surname: Esposito
  fullname: Esposito, Bruno
– sequence: 9
  givenname: Florence
  orcidid: 0000-0002-5471-1487
  surname: Pinet
  fullname: Pinet, Florence
– sequence: 10
  givenname: Patrick
  orcidid: 0000-0002-2350-2914
  surname: Bruneval
  fullname: Bruneval, Patrick
– sequence: 11
  givenname: Juliette
  surname: Raffort
  fullname: Raffort, Juliette
– sequence: 12
  givenname: Fabien
  orcidid: 0000-0002-6765-8021
  surname: Lareyre
  fullname: Lareyre, Fabien
– sequence: 13
  givenname: Jose
  surname: Vilar
  fullname: Vilar, Jose
– sequence: 14
  givenname: Amir
  surname: Boufenzer
  fullname: Boufenzer, Amir
– sequence: 15
  givenname: Lea
  surname: Guyonnet
  fullname: Guyonnet, Lea
– sequence: 16
  givenname: Coralie
  surname: Guerin
  fullname: Guerin, Coralie
– sequence: 17
  givenname: Eric
  orcidid: 0000-0003-1535-869X
  surname: Clauser
  fullname: Clauser, Eric
– sequence: 18
  givenname: Jean-Sébastien
  orcidid: 0000-0003-3962-2205
  surname: Silvestre
  fullname: Silvestre, Jean-Sébastien
– sequence: 19
  givenname: Sylvie
  surname: Lang
  fullname: Lang, Sylvie
– sequence: 20
  givenname: Laurie
  surname: Soulat-Dufour
  fullname: Soulat-Dufour, Laurie
– sequence: 21
  givenname: Alain
  orcidid: 0000-0002-7229-4875
  surname: Tedgui
  fullname: Tedgui, Alain
– sequence: 22
  givenname: Ziad
  orcidid: 0000-0003-0443-7878
  surname: Mallat
  fullname: Mallat, Ziad
– sequence: 23
  givenname: Soraya
  orcidid: 0000-0002-6650-619X
  surname: Taleb
  fullname: Taleb, Soraya
– sequence: 24
  givenname: Alexandre
  orcidid: 0000-0002-7770-7210
  surname: Boissonnas
  fullname: Boissonnas, Alexandre
– sequence: 25
  givenname: Marc
  orcidid: 0000-0002-8707-5923
  surname: Derive
  fullname: Derive, Marc
– sequence: 26
  givenname: Giulia
  surname: Chinetti
  fullname: Chinetti, Giulia
– sequence: 27
  givenname: Hafid
  surname: Ait-Oufella
  fullname: Ait-Oufella, Hafid
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33258804$$D View this record in MEDLINE/PubMed
https://inserm.hal.science/inserm-03833065$$DView record in HAL
BookMark eNqN091u0zAUAOAIDbEfuOAFUCQkBBLZ7NpOnBukqhqsqGjSGNxarn2SeiR2sZNpveMdeEOeBEfdunX0AuUikfOd43P8c5jsWWchSV5idIxxMTr5PJliOqI5f5IcYMZ4xkeE7yUHCI1wVhaE7yeHIVwhhCll9FmyT8iIcY7oQdJfXpx-yXDqvFpA6LzsIKTS1sZ1YIOx6XT659dvY3WvQKets06tOkgjrCqjfhhbR63TpXetG0LhZgnetGA72aRyrl1r7PDlfGdUpND7VWifJ08r2QR4cfs-Sr59PL2cnGWz80_TyXiWqQKjLpNSMqLLirCSqUIB5QXQssBzjstCg2allkopPadS5mReEQCdc0WQRpRCBeQo-bDOu-znLWgVy_KyEctYofQr4aQR23-sWYjaXYuCY0SLPCZ4v06weBR2Np4JYwP4ViDCCUE5u8aRv72dz7uffVxP0ZqgoGli464PIu5RHnmJUaSvH9Er1_u4VlExVBaozBm9V7VsIE5YuVimGpKKcU5LwhArB5XtUDVYiD3Fo1KZOLzlj3f4-GhojdoZ8G4rIJoObrpa9iGI6deL_7fn37ftmwd2AbLpFsE1fWecDdvw1cON3GzF3UGO4GQNlHcheKiEMp0c8sTWTCMwEsNVEZurcl_nJuIu6b_2L3ZTEiE
CitedBy_id crossref_primary_10_1155_2022_4838760
crossref_primary_10_1016_j_autrev_2022_103258
crossref_primary_10_3389_fcvm_2023_1098914
crossref_primary_10_1016_j_phrs_2022_106473
crossref_primary_10_1007_s10863_025_10065_y
crossref_primary_10_1016_j_heliyon_2024_e27989
crossref_primary_10_3389_fcell_2025_1554972
crossref_primary_10_1161_CIRCRESAHA_124_324366
crossref_primary_10_1371_journal_pone_0308273
crossref_primary_10_1038_s41401_023_01123_5
crossref_primary_10_1186_s12967_023_04027_4
crossref_primary_10_3389_fcvm_2022_941185
crossref_primary_10_1186_s12872_024_04077_6
crossref_primary_10_1016_j_pharmthera_2022_108182
crossref_primary_10_1038_s41421_022_00402_5
crossref_primary_10_3389_fmicb_2022_1042200
crossref_primary_10_1038_s41577_023_00837_1
crossref_primary_10_3389_fgene_2022_1055396
crossref_primary_10_1016_j_heliyon_2023_e20881
crossref_primary_10_3389_fimmu_2022_989933
crossref_primary_10_1007_s11883_025_01302_1
crossref_primary_10_1016_j_biopha_2022_113467
crossref_primary_10_3390_biomedicines10010094
crossref_primary_10_3390_biom13010060
crossref_primary_10_1016_j_jaut_2024_103296
crossref_primary_10_1038_s41419_025_07333_5
crossref_primary_10_1016_j_gene_2023_148068
crossref_primary_10_1186_s12957_023_03013_w
crossref_primary_10_1096_fj_202402873R
crossref_primary_10_1038_s41422_021_00493_x
crossref_primary_10_1016_j_cell_2023_08_033
crossref_primary_10_1016_j_nano_2022_102564
crossref_primary_10_1016_j_intimp_2024_113274
crossref_primary_10_1039_D3FO01235B
crossref_primary_10_3389_fcvm_2025_1670576
crossref_primary_10_1016_j_bcp_2025_116800
crossref_primary_10_1016_j_csbj_2023_10_052
crossref_primary_10_1186_s11658_025_00768_w
crossref_primary_10_1016_j_yexcr_2024_114286
crossref_primary_10_1002_pep2_70001
crossref_primary_10_1007_s11010_024_05173_z
crossref_primary_10_1007_s12013_024_01377_8
crossref_primary_10_1038_s41421_021_00362_2
crossref_primary_10_1098_rsob_210172
crossref_primary_10_25259_Cytojournal_80_2024
crossref_primary_10_31083_RCM33511
crossref_primary_10_1016_j_bbrc_2025_152589
crossref_primary_10_1016_j_celrep_2025_115380
crossref_primary_10_1038_s41467_022_34469_1
crossref_primary_10_3390_biom13020399
crossref_primary_10_1016_j_cellsig_2024_111458
crossref_primary_10_1038_s41598_025_14781_8
crossref_primary_10_1097_CM9_0000000000003197
Cites_doi 10.1172/JCI15334
10.1097/ALN.0000000000000078
10.1161/01.ATV.0000085631.76095.64
10.1038/nrcardio.2017.52
10.2174/1570161115666170413145705
10.1172/JCI64181
10.1155/2018/7213760
10.1177/1538574418784717
10.1111/j.1365-2567.2009.03091.x
10.1186/cc3732
10.1096/fj.201500088R
10.1371/journal.pone.0182226
10.1161/01.ATV.15.8.1145
10.1172/JCI28764
10.1172/JCI2182
10.1097/HCO.0000000000000216
10.1172/JCI67356
10.1038/s41598-017-04438-6
10.1161/CIRCRESAHA.116.305628
10.1097/SHK.0b013e31827bcdfb
10.1016/j.jss.2006.03.026
10.1172/JCI38136
10.1016/j.matbio.2015.01.015
10.1161/ATVBAHA.112.300329
10.1002/hep.29276
10.1161/CIRCULATIONAHA.104.517391
10.1016/j.coi.2009.01.009
10.1038/hr.2015.55
10.17305/bjbms.2012.2503
10.1126/science.1175202
10.1084/jem.20040708
10.1038/ki.2014.205
10.1038/nrcardio.2010.180
10.11613/BM.2018.030702
10.1161/ATVBAHA.108.173898
10.4049/jimmunol.180.5.3520
10.1161/CIRCULATIONAHA.113.006800
10.1111/bcp.13668
10.1161/ATVBAHA.114.304389
10.1016/j.pharmthera.2017.02.043
10.4049/jimmunol.0803164
10.1172/JCI7818
10.1007/s00134-020-06109-z
10.1038/35074114
10.4049/jimmunol.164.10.4991
10.1016/j.jacc.2016.10.015
10.4049/jimmunol.1102674
ContentType Journal Article
Copyright COPYRIGHT 2021 American Society for Clinical Investigation
Copyright American Society for Clinical Investigation Jan 2021
Distributed under a Creative Commons Attribution 4.0 International License
2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation
Copyright_xml – notice: COPYRIGHT 2021 American Society for Clinical Investigation
– notice: Copyright American Society for Clinical Investigation Jan 2021
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: 2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7RV
7X7
7XB
88A
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
S0X
7X8
1XC
5PM
DOI 10.1172/JCI142468
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
SIRS Editorial
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
elibrary
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest Central Student
MEDLINE - Academic

MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-8238
EndPage 14
ExternalDocumentID PMC7810476
oai:HAL:inserm-03833065v1
A649350594
33258804
10_1172_JCI142468
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GrantInformation_xml – fundername: British Heart Foundation
  grantid: RG/15/11/31593
– fundername: British Heart Foundation
  grantid: CH/10/001/27642
– fundername: ANR
  grantid: ANR-18-CE14-0009-01
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
5GY
5RE
5RS
7RV
7X7
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
AAYXX
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
ADPDF
AEAQA
AENEX
AFCHL
AFFHD
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M1P
M5~
M7P
NAPCQ
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
88A
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
1XC
5PM
ID FETCH-LOGICAL-c710t-aaa53d9f3595c7ce487e4971b8197ded59dacccdb4aa63bf3eed68c30d044efe3
IEDL.DBID 7X7
ISICitedReferencesCount 66
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000612230300010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0021-9738
1558-8238
IngestDate Tue Nov 04 02:04:51 EST 2025
Tue Oct 14 20:23:47 EDT 2025
Thu Oct 02 05:55:14 EDT 2025
Tue Oct 07 05:20:33 EDT 2025
Sat Nov 29 13:21:30 EST 2025
Sat Nov 29 11:13:47 EST 2025
Sat Nov 29 10:16:49 EST 2025
Wed Nov 26 10:42:28 EST 2025
Wed Nov 26 09:26:29 EST 2025
Thu May 22 21:15:59 EDT 2025
Mon Jul 21 05:34:47 EDT 2025
Sat Nov 29 01:34:35 EST 2025
Tue Nov 18 22:04:51 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Innate immunity
Monocytes
Inflammation
Cell migration/adhesion
Vascular Biology
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c710t-aaa53d9f3595c7ce487e4971b8197ded59dacccdb4aa63bf3eed68c30d044efe3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC7810476
Authorship note: YZ and ISZ contributed equally to the work.
ORCID 0000-0002-7770-7210
0000-0002-7229-4875
0000-0003-1535-869X
0000-0002-2350-2914
0000-0002-0982-858X
0000-0002-6765-8021
0000-0002-6976-0011
0000-0002-8707-5923
0000-0003-3962-2205
0000-0002-6947-9852
0000-0002-6650-619X
0000-0002-5471-1487
0000-0003-0443-7878
OpenAccessLink http://www.jci.org/articles/view/142468/files/pdf
PMID 33258804
PQID 2509709654
PQPubID 42166
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7810476
hal_primary_oai_HAL_inserm_03833065v1
proquest_miscellaneous_2466038910
proquest_journals_2509709654
gale_infotracmisc_A649350594
gale_infotracgeneralonefile_A649350594
gale_infotracacademiconefile_A649350594
gale_incontextgauss_ISR_A649350594
gale_incontextgauss_IOV_A649350594
gale_healthsolutions_A649350594
pubmed_primary_33258804
crossref_citationtrail_10_1172_JCI142468
crossref_primary_10_1172_JCI142468
PublicationCentury 2000
PublicationDate 2021-01-19
PublicationDateYYYYMMDD 2021-01-19
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-19
  day: 19
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Ann Arbor
PublicationTitle The Journal of clinical investigation
PublicationTitleAlternate J Clin Invest
PublicationYear 2021
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
References B20
B42
B21
B43
B22
B44
B23
B45
B24
B46
B25
B47
B27
B28
Li (B40) 2018; 2018
B30
B31
B10
B32
B11
B33
B12
B13
B35
B14
B36
B15
B37
B16
B38
B17
B39
B18
B19
B1
B2
B3
B4
B5
B6
B7
Johnston (B26) 2014; 130
Eagleton (B29) 2006; 135
B8
B9
Newby (B34) 2015; 44–46
B41
References_xml – ident: B30
  doi: 10.1172/JCI15334
– ident: B15
  doi: 10.1097/ALN.0000000000000078
– ident: B22
  doi: 10.1161/01.ATV.0000085631.76095.64
– ident: B23
  doi: 10.1038/nrcardio.2017.52
– ident: B39
  doi: 10.2174/1570161115666170413145705
– ident: B11
  doi: 10.1172/JCI64181
– volume: 2018
  year: 2018
  ident: B40
  article-title: Modulation of immune-inflammatory responses in abdominal aortic aneurysm: emerging molecular targets
  publication-title: J Immunol Res
  doi: 10.1155/2018/7213760
– ident: B43
  doi: 10.1177/1538574418784717
– ident: B17
  doi: 10.1111/j.1365-2567.2009.03091.x
– ident: B35
  doi: 10.1186/cc3732
– ident: B24
  doi: 10.1096/fj.201500088R
– ident: B25
  doi: 10.1371/journal.pone.0182226
– ident: B28
  doi: 10.1161/01.ATV.15.8.1145
– ident: B21
  doi: 10.1172/JCI28764
– ident: B32
  doi: 10.1172/JCI2182
– ident: B2
  doi: 10.1097/HCO.0000000000000216
– ident: B4
  doi: 10.1172/JCI67356
– ident: B46
  doi: 10.1038/s41598-017-04438-6
– ident: B12
  doi: 10.1161/CIRCRESAHA.116.305628
– ident: B14
  doi: 10.1097/SHK.0b013e31827bcdfb
– volume: 135
  start-page: 345
  issue: 2
  year: 2006
  ident: B29
  article-title: Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2006.03.026
– ident: B31
  doi: 10.1172/JCI38136
– volume: 44–46
  start-page: 157
  year: 2015
  ident: B34
  article-title: Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation
  publication-title: Matrix Biol
  doi: 10.1016/j.matbio.2015.01.015
– ident: B5
  doi: 10.1161/ATVBAHA.112.300329
– ident: B47
  doi: 10.1002/hep.29276
– ident: B6
  doi: 10.1161/CIRCULATIONAHA.104.517391
– ident: B10
  doi: 10.1016/j.coi.2009.01.009
– ident: B38
  doi: 10.1038/hr.2015.55
– ident: B36
  doi: 10.17305/bjbms.2012.2503
– ident: B20
  doi: 10.1126/science.1175202
– ident: B19
  doi: 10.1084/jem.20040708
– ident: B37
  doi: 10.1038/ki.2014.205
– ident: B1
  doi: 10.1038/nrcardio.2010.180
– ident: B44
  doi: 10.11613/BM.2018.030702
– ident: B33
  doi: 10.1161/ATVBAHA.108.173898
– ident: B18
  doi: 10.4049/jimmunol.180.5.3520
– volume: 130
  start-page: S51
  issue: 11 Suppl 1
  year: 2014
  ident: B26
  article-title: Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.006800
– ident: B41
  doi: 10.1111/bcp.13668
– ident: B3
  doi: 10.1161/ATVBAHA.114.304389
– ident: B9
  doi: 10.1016/j.pharmthera.2017.02.043
– ident: B27
  doi: 10.4049/jimmunol.0803164
– ident: B16
  doi: 10.1172/JCI7818
– ident: B42
  doi: 10.1007/s00134-020-06109-z
– ident: B8
  doi: 10.1038/35074114
– ident: B7
  doi: 10.4049/jimmunol.164.10.4991
– ident: B45
  doi: 10.1016/j.jacc.2016.10.015
– ident: B13
  doi: 10.4049/jimmunol.1102674
SSID ssj0014454
Score 2.5872624
Snippet The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic...
SourceID pubmedcentral
hal
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1
SubjectTerms Abdomen
Abdominal aneurysm
Adapter proteins
Aneurysms
Angiotensin
Angiotensin II
Angiotensin II - adverse effects
Angiotensin II - pharmacology
Animals
Aorta
Aortic Aneurysm, Abdominal - chemically induced
Aortic Aneurysm, Abdominal - genetics
Aortic Aneurysm, Abdominal - metabolism
Aortic Aneurysm, Abdominal - pathology
Aortic aneurysms
Apolipoprotein E
Atherosclerosis
Biomedical research
Blood pressure
Cardiovascular diseases
Cardiovascular system
Cell activation
Cell Movement - drug effects
Cell Movement - genetics
Chemokines
Coronary vessels
Cytokines
Development and progression
Flow cytometry
Gelatinase A
Gelatinase B
Gene Deletion
Gene expression
Health aspects
Human health and pathology
Humans
Inflammation
Interleukin-1beta - genetics
Interleukin-1beta - metabolism
L-selectin
Life Sciences
Macrophages
Matrix Metalloproteinase 2 - genetics
Matrix Metalloproteinase 2 - metabolism
Membrane proteins
Mice
Mice, Knockout, ApoE
Monocytes
Monocytes - metabolism
Monocytes - pathology
Myeloid cells
Neutrophils
Pathophysiology
Peptides
Physiological aspects
Spleen
Therapeutic targets
Triggering Receptor Expressed on Myeloid Cells-1 - genetics
Triggering Receptor Expressed on Myeloid Cells-1 - metabolism
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - metabolism
Title TREM-1 orchestrates angiotensin II–induced monocyte trafficking and promotes experimental abdominal aortic aneurysm
URI https://www.ncbi.nlm.nih.gov/pubmed/33258804
https://www.proquest.com/docview/2509709654
https://www.proquest.com/docview/2466038910
https://inserm.hal.science/inserm-03833065
https://pubmed.ncbi.nlm.nih.gov/PMC7810476
Volume 131
WOSCitedRecordID wos000612230300010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: M7P
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: 7X7
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: 7RV
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1558-8238
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014454
  issn: 0021-9738
  databaseCode: BENPR
  dateStart: 20020701
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbYhhAv3C-FUQICxou1Jnbi5AmVqdOKWKnKmPoWObbTVWJJadpJvPEf-If8Es5x3dDAhJB4yYu_OLZ8fC7O8XcIeSElD2VuDA1DoSjnQtMENCVNwDfgucyDLMtssQkxGMTjcTJ0B26VS6tc60SrqHWp8Ix8H0x1IpCqhL-ZfaFYNQr_rroSGltkB8tmo5yLcR1wQawQOhZmnyaCxY5ZCGz2_ruDPt7xQobVDXvktPLWGSZF_ulx_p44uWGJDm_-7xxukRvOB_W6K6G5Ta6Y4g65duz-st8ly5NR75j6Xjm31bSQTKLyZDGZljbdvfD6_R_fvkMwD2KhPei0VF8XxgMg8lHg2TugtTezmX7w6mYVAU9murSFxDxZ4gAAamBdq_N75NNh7-TgiLryDFSBW7KgUsqQ6STHq71KKAOhj-GJ8DNwMoQ2Oky0VErpjEsZsSxnYI6jWLGO7nBucsPuk-2iLMxD4iUsViLUQosw41rzLGAm9lkWSVjCSKsWeb1epFQ57nIsofE5tTGMCNJ6PVvkeQ2drQg7LgM9xZVOV3dN602ediOesBApbKAbi0CKjAJzcCZyWVVp_8PpP4A-jhqgPQfKSxizku7eA8wcqbcayFcN5GRFPH4ZcLcBBI2gGs0vQYDr2SOB-FH3PaBBqZ2nHRYziBPDCx-6WYtp6jRXlf6S0RZ5VjfjFzAbrzDlEjA8ipCY0e-0yIPVjqi_xlgQgk2At0VjrzSG02wppmeW11zEyBsSPfr7sB6T6wFu6I5P_WSXbC_mS_OEXFUXi2k1b4MCGJ22rRqwz7hNdt72BsNRG7N6hz8BW7RrOg
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtNAFB21BQEb3o9AoQZRYGPV9ow99gKhqLSKaRKqElB3ZjwzTiNRO8RJUXf8A__BR_El3OsXMVSITRes53g8k9zXeO49l5CnQjBXJFqbrsulyRhXZgCW0gwgNmCJSJw4jotmE3w49A8Pg_0V8r2uhcG0ytomFoZaZRK_kW-Bqw44UpWwV9PPJnaNwtvVuoVGKRZ7-vQLHNnyl-Fr-H83HWd3Z7TdM6uuAqYEbzo3hRAuVUGCFamSSw0Ru2YBt2PwjVxp5QZKSClVzITwaJxQ8CKeL6mlLMZ0oinMu0ouQBjhWEWq4H5za8GYW7E-22bAqV8xGUGMsPVmO8SaMmR0XfJ_lRdYPcIkzD8j3N8TNZc83-61_-03u06uVjG20S2V4gZZ0elNcmlQZRHcIovRwc7AtI1sVnQLQ7KM3BDpeJIV6fypEYY_vn6bpArEXhmwiUyezrUBQOTbwLsFQCtjWmQywqPLXRIMEausaJRmiAwXAFANcpsf3ybvz2XTd8hamqX6HjEC6kvuKq64GzOlWOxQ7ds09gSIjKdkh7yohSKSFTc7tgj5FBVnNO5Ejfx0yJMGOi0JSc4CbaBkRWUtbWPEoq7HAuoiRQ9MUyCQAiTFHKOxWOR5FL798A-gdwct0PMKlGSwZimqug7YOVKLtZDPWshxSax-FnC9BQSLJ1vDm6Awze6RIL3X7QMajPZxZFGfwjnYPbFhmlotosoy59EvneiQx80wvgGzDVOdLQDDPA-JJ22rQ-6WGti8jVLHBZ8HT_OWbraW0x5JJ0cFbzv3kRfFu__3ZW2Qy73RoB_1w-HeA3LFQWNi2aYdrJO1-WyhH5KL8mQ-yWePCuNjkI_nrbk_AbiVyBM
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEF61Kaq48P8TKNQgClysxN611z4gFNpENW1DlBbUm1nvrtNI1A5xUtQb78Db8Dg8CTO2Y2KoEJceOO_n9W4yf-ud-YaQZ0IwR8Ram47DpckYV6YPltL0ITZgsYjtKIryZhO83_eOj_3BCvm-qIXBtMqFTcwNtUolfiNvgav2OVKVsFZcpkUMdnqvJ59N7CCFN62LdhqFiOzp8y9wfMteBTvwX2_Zdq97tL1rlh0GTAmedWYKIRyq_BirUyWXGqJ3zXxuReAnudLK8ZWQUqqICeHSKKbgUVxP0rZqM6ZjTWHeVbLGKRx6GmTtTbc_GFZ3GIw5JQe0ZfqceiWvEUQMrbfbAVaYIb_rkjcsfcLqCaZk_hnv_p62ueQHe9f_51_wBrlWRt9Gp1CXm2RFJ7fI-kGZX3CbzI-G3QPTMtJp3kcMaTQyQySjcZon-idGEPz4-m2cKFAIZcAmUnk-0wYAkYkDbx0ArYxJnuMIjy73TzBEpNK8hZohUlwAQDVIdHZ6h7y_lE3fJY0kTfR9YvjUk9xRXHEnYkqxyKbas2jkChAfV8kmebkQkFCWrO3YPORTmJ_euB1WstQkTyvopKAquQi0iVIWFlW2lXkLOy7zqYPkPTBNjkBykASFZCTmWRYG7z78A-hwWAO9KEFxCmuWoqz4gJ0j6VgN-byGHBWU6xcBN2pAsIWyNrwFylPtHqnTdzv7gAZzfhq2qUfhhOycWTDNQkXC0mZn4S_9aJIn1TC-AfMQE53OAcNcFykprXaT3Cu0sXobpbYD3hCe5jU9rS2nPpKMT3JGd-4hY4r74O_L2iTroLDhftDfe0iu2mhX2pZp-RukMZvO9SNyRZ7Nxtn0cWmJDPLxslX3J8Pn0is
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TREM-1+orchestrates+angiotensin+II-induced+monocyte+trafficking+and+promotes+experimental+abdominal+aortic+aneurysm&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Guyonnet%2C+Lea&rft.au=Zhang%2C+Yujiao&rft.au=Derive%2C+Marc&rft.au=Guerin%2C+Coralie&rft.date=2021-01-19&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=131&rft.issue=2&rft_id=info:doi/10.1172%2Fjci142468&rft.externalDBID=n%2Fa&rft.externalDocID=A649350594
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon